Ocular Therapeutix, Inc.
(NASDAQ : OCUL)

( )
OCUL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
-5.91%22.601.7%$237.34m
VRXValeant Pharmaceuticals International, Inc.
-0.26%28.4114.1%$167.17m
BHCBausch Health Cos., Inc.
-0.26%28.410.0%$118.77m
MDCOThe Medicines Co.
12.83%58.6520.2%$91.08m
GWPHGW Pharmaceuticals Plc
-5.48%102.476.2%$78.16m
JAZZJazz Pharmaceuticals Plc
-0.01%138.622.3%$64.50m
SAGESAGE Therapeutics, Inc.
-0.25%145.968.6%$52.79m
PRGOPerrigo Co. Plc
-0.83%48.976.8%$49.60m
ENDPEndo International Plc
-1.66%4.468.8%$44.83m
UTHRUnited Therapeutics Corp.
0.25%90.6614.3%$39.62m
HZNPHorizon Therapeutics Plc
1.54%30.736.6%$39.53m
ICPTIntercept Pharmaceuticals, Inc.
0.92%83.0116.9%$39.17m
ICLRICON plc
-0.38%154.014.2%$37.55m
CTLTCatalent, Inc.
0.02%50.432.4%$31.88m
ARGXargenx SE
1.52%141.490.0%$26.87m

Company Profile

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline include Dextenza, OTX-TP, and OTX-TIC . The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.